Skip to main content
. 2015 Feb 17;32(2):120–137. doi: 10.1007/s12325-015-0182-8

Fig. 1.

Fig. 1

Reduction in resting heart rate with initiation of ivabradine in patients with stable angina on top of optimal medical therapy including beta-blockers who underwent previous percutaneous coronary intervention (PCI) and those who did not (No PCI). P value describes change between baseline and month 1 and baseline and month 4 for both subgroups. bpm beats per minute